Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
J Adolesc Health ; 72(1): 12-20, 2023 01.
Artigo em Inglês | MEDLINE | ID: mdl-36202679

RESUMO

PURPOSE: The aim of this study is to assess the level of agreement between adolescents' self-assessment and parent-proxy reports on health-related quality of life (HRQOL) in Jamaican adolescents with chronic illness. METHODS: A cross-sectional study was conducted, recruiting adolescents living with a chronic illness (ALCIs)-asthma, human immunodeficiency virus, insulin-dependent diabetes mellitus, or sickle cell disease and age/sex-matched healthy adolescents. Data were collected on HRQOL from adolescents and parents using the Pediatric Quality of Life Scale. Parent-adolescent agreement was determined at group level (Wilcoxon signed-rank test) and individual level (intraclass correlation coefficient). RESULTS: Two hundred twenty-six (226) parent/adolescent pairs participated: 130 ALCIs and 96 healthy peers; mean age 14.9 ± 2.8 years; 58% females. Adolescents with and without chronic illness reported similar HRQOL; parent-proxies reported better HRQOL for healthy adolescents compared to ALCIs. Intraclass correlation demonstrated higher levels of parent-adolescent correlation for ALCIs than healthy adolescents (ALCIs: 0.11-0.34; healthy adolescents: 0.01-0.10). At group level, analyses demonstrated better parent-proxy rating of QOL in all of the scores with the exception of the general health score. Parent-proxies overestimated QOL for asthma and insulin-dependent diabetes mellitus but not for sickle cell disease and human immunodeficiency virus. Linear regression modeling revealed that female sex and living with chronic illness were significant predictors of agreement. DISCUSSION: Parent-proxies overestimated adolescents' QOL compared to adolescents' report regardless of whether the adolescent was living with a chronic illness or not. As such, health care providers should elicit feedback from the adolescent wherever possible and proxy reports should be used as complementary information rather than primary source.


Assuntos
Anemia Falciforme , Asma , Diabetes Mellitus Tipo 1 , Adolescente , Criança , Feminino , Humanos , Masculino , Qualidade de Vida , Estudos Transversais , Jamaica , Procurador , Doença Crônica
2.
J Dermatolog Treat ; 33(3): 1507-1510, 2022 May.
Artigo em Inglês | MEDLINE | ID: mdl-33043730

RESUMO

BACKGROUND: Many patients with atopic dermatitis seek care from both primary care physicians and dermatologists. However, little is known regarding topical corticosteroid prescribing patterns among these specialties. OBJECTIVE: We sought to determine if differences exist in topical corticosteroid prescribing patterns among dermatologists, family medicine physicians, and internal medicine physicians. METHODS: We conducted a population-based, cross-sectional analysis using data from the U.S. National Ambulatory Medical Care Survey from 2006 to 2016. RESULTS: Compared to dermatologists, internal medicine physicians were 22 times less likely to prescribe a topical corticosteroid for atopic dermatitis (52.2% versus 5.1%, p = .001; adjusted OR 0.045, 95%CI 0.007-0.277). There was not a statistically significant difference in the rate of topical corticosteroid prescriptions for atopic dermatitis between family medicine physicians and dermatologists (39.1% vs. 52.2%, p = .27; adjusted OR 0.468, 95%CI 0.174-1.257). Family medicine physicians had a higher rate of prescribing topical corticosteroids for atopic dermatitis than internal medicine physicians (39.1% vs. 5.1%, p = .002). LIMITATIONS: Severity of atopic dermatitis was not assessed. CONCLUSIONS: Atopic dermatitis patients seen by internal medicine physicians are much less likely to receive topical corticosteroid prescriptions as compared to those seen by dermatologists.


Assuntos
Dermatite Atópica , Fármacos Dermatológicos , Estudos Transversais , Dermatite Atópica/tratamento farmacológico , Dermatite Atópica/epidemiologia , Fármacos Dermatológicos/uso terapêutico , Dermatologistas , Glucocorticoides/uso terapêutico , Humanos , Atenção Primária à Saúde
5.
Cutis ; 107(2): 104-106, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-33891842

RESUMO

Immunocompromised patients, such as organ transplant recipients, require careful benefit-risk consideration when selecting a systemic agent for psoriasis. Brodalumab is an immunomodulatory biologic that binds to and inhibits IL-17RA, thereby inhibiting the actions of IL-17A, F, E, and C. Brodalumab has a rapid onset of action, sustained efficacy, and an acceptable safety profile, all of which serve to enhance its appeal as a systemic treatment option for psoriasis in immunocompromised patients. Reports of brodalumab use for psoriasis in organ transplant recipients are limited. We report a case in which brodalumab was used to treat psoriasis in a patient who had undergone solid organ transplantation with excellent response and good tolerability.


Assuntos
Transplante de Órgãos , Psoríase , Anticorpos Monoclonais , Anticorpos Monoclonais Humanizados , Humanos , Psoríase/tratamento farmacológico
6.
Plant Mol Biol ; 105(1-2): 99-114, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-32964370

RESUMO

KEY MESSAGE: This manuscript describes the functions of an Argonaute protein named AGO17 in rice. AGO17 is required for the development of rice reproductive tissues. Argonaute (AGO) proteins are a well-conserved multigene family of regulators mediating gene silencing across eukaryotes. Monocot plants have additional members of AGO, the functions of which are poorly understood. Among the non-dicot AGO1 clade members in monocots, AGO17 expresses highly in reproductive tissues. Here we show that overexpression of Oryza sativa indica AGO17 in rice resulted in robust growth and increased yield, whereas its silencing resulted in reduced panicle length, less fertility, and poor growth. Small (s)RNA transcriptome analysis revealed misregulation of several miRNAs and other categories of sRNAs in silenced and overexpression lines, in agreement with its likely competition with other AGO1 clade members. Targets of differentially expressed miRNAs included previously unreported target RNAs coding for proteins involved in development, phase transition, and transport. Our results indicate a distinctive role for OsAGO17 in rice reproductive development that could be harnessed to improve yield.


Assuntos
Proteínas Argonautas/genética , Proteínas Argonautas/metabolismo , Oryza/genética , Oryza/metabolismo , Fenótipo , Arabidopsis , Perfilação da Expressão Gênica , Regulação da Expressão Gênica de Plantas , Técnicas de Silenciamento de Genes , Inativação Gênica , MicroRNAs/genética , MicroRNAs/metabolismo , Plantas Geneticamente Modificadas , Pólen/metabolismo , RNA de Plantas/genética , Reprodução/fisiologia , Análise de Sequência de RNA , Transcriptoma
8.
Dermatol Online J ; 26(10)2020 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-33147660

RESUMO

Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential risk of SARS-CoV-2 infection. This article includes an overview of the up-to-date international and U.S. treatment guidelines for psoriasis, atopic dermatitis, hidradenitis suppurativa, and acne/rosacea; it provides tables summarizing these resources to assist providers and patients in remaining updated regarding recommended treatment modifications during the pandemic (See Tables 1-4).


Assuntos
Betacoronavirus , Infecções por Coronavirus/epidemiologia , Dermatite Atópica/tratamento farmacológico , Hidradenite Supurativa/tratamento farmacológico , Pneumonia Viral/epidemiologia , Psoríase/tratamento farmacológico , Rosácea/tratamento farmacológico , Produtos Biológicos/uso terapêutico , COVID-19 , Infecções por Coronavirus/complicações , Infecções por Coronavirus/transmissão , Humanos , Imunossupressores , Internacionalidade , Pandemias , Pneumonia Viral/complicações , Pneumonia Viral/transmissão , SARS-CoV-2 , Estados Unidos
9.
Transl Behav Med ; 7(2): 157-165, 2017 06.
Artigo em Inglês | MEDLINE | ID: mdl-27909881

RESUMO

Recruiting pregnant smokers into clinical trials is challenging since this population tends to be disadvantaged, the behavior is stigmatized, and the intervention window is limited. The purpose of this study is to test the feasibility and effectiveness of recruiting pregnant smokers into a smoking cessation trial by sending recruitment text messages to an existing subscriber list. Recruitment messages were sent to subscribers flagged as pregnant in Text4baby, a national text messaging program for pregnant women and mothers. Four recruitment messages were rotated to test the effectiveness of different emotional frames and a financial incentive. Study staff called subscribers who expressed interest to screen for eligibility and enroll eligible women. Between October 6, 2015 and February 2, 2016, 10,194 recruitment messages were sent to Text4baby subscribers flagged as pregnant, and 10.18% (1038) responded indicating interest. No significant increase in cancellation was observed compared to subscribers who received other ad hoc messages. Of respondents, 54.05% (561) were reached by phone for follow-up, and 21.97% (228) were found to be eligible. Among the eligible, 87% (199) pregnant smokers enrolled. The recruitment message with a pride emotional appeal had a significantly higher response (p = 0.02) compared to the recruitment message with no emotional appeal, but enrollment did not significantly differ between recruitment messages with different emotional appeals. The recruitment messages with a reference to financial incentive yielded higher response (p < 0.01) and enrollment (p = 0.03) compared to a recruitment message without. This study demonstrates success recruiting pregnant smokers using text message. Future studies should consider building on this approach for recruiting high-risk populations.


Assuntos
Seleção de Pacientes , Complicações na Gravidez/terapia , Abandono do Hábito de Fumar , Fumar/terapia , Envio de Mensagens de Texto , Adulto , Emoções , Estudos de Viabilidade , Feminino , Seguimentos , Humanos , Gravidez , Gestantes/psicologia , Recompensa , Fumantes/psicologia , Fumar/psicologia , Abandono do Hábito de Fumar/métodos , Telefone
10.
Am J Psychiatry ; 168(3): 286-92, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21205805

RESUMO

OBJECTIVE: This study examined the effect of medication nonadherence on the return of positive symptoms among recent-onset schizophrenia patients. METHOD: Three sets of operational criteria for medication nonadherence with differing levels of severity were compared for their ability to predict relapse. Explicit operational criteria are provided with the hope that they will be adopted by others. Psychotic symptoms were prospectively rated on a frequent basis, and systematic criteria were applied using a computer scoring program to identify periods of psychotic symptom return. In addition, a specialized statistical survival analysis method, optimal for examining risk periods and outcomes that can recur during the follow-up assessment, was used. RESULTS: As hypothesized, medication nonadherence robustly predicted a return of psychotic symptoms during the early phase of schizophrenia (hazard ratios=3.7-28.5, depending on the severity of nonadherence). CONCLUSIONS: Even brief periods of partial nonadherence lead to greater risk of relapse than what is commonly assumed. Patients in the early phase of schizophrenia should be cautioned about the possible consequences of partial or relatively brief periods of antipsychotic medication nonadherence.


Assuntos
Adesão à Medicação/psicologia , Risperidona/uso terapêutico , Esquizofrenia/tratamento farmacológico , Esquizofrenia/prevenção & controle , Adulto , Feminino , Humanos , Estudos Longitudinais , Masculino , Esquizofrenia/diagnóstico , Psicologia do Esquizofrênico , Prevenção Secundária
11.
Theor Appl Genet ; 122(6): 1091-103, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21188349

RESUMO

Oil content and oil quality fractions (viz., oleic, linoleic and linolenic acid) are strongly influenced by the erucic acid pathway in oilseed Brassicas. Low levels of erucic acid in seed oil increases oleic acid content to nutritionally desirable levels, but also increases the linoleic and linolenic acid fractions and reduces oil content in Indian mustard (Brassica juncea). Analysis of phenotypic variability for oil quality fractions among a high-erucic Indian variety (Varuna), a low-erucic east-European variety (Heera) and a zero-erucic Indian variety (ZE-Varuna) developed by backcross breeding in this study indicated that lower levels of linoleic and linolenic acid in Varuna are due to substrate limitation caused by an active erucic acid pathway and not due to weaker alleles or enzyme limitation. To identify compensatory loci that could be used to increase oil content and maintain desirable levels of oil quality fractions under zero-erucic conditions, we performed Quantitative Trait Loci (QTL) mapping for the above traits on two independent F1 doubled haploid (F1DH) mapping populations developed from a cross between Varuna and Heera. One of the populations comprised plants segregating for erucic acid content (SE) and was used earlier for construction of a linkage map and QTL mapping of several yield-influencing traits in B. juncea. The second population consisted of zero-erucic acid individuals (ZE) for which, an Amplified Fragment Length Polymorphism (AFLP)-based framework linkage map was constructed in the present study. By QTL mapping for oil quality fractions and oil content in the ZE population, we detected novel loci contributing to the above traits. These loci did not co-localize with mapped locations of the fatty acid desaturase 2 (FAD2), fatty acid desaturase 3 (FAD3) or fatty acid elongase (FAE) genes unlike those of the SE population wherein major QTL were found to coincide with mapped locations of the FAE genes. Some of the new loci identified in the ZE population could be detected as 'weak' contributors (with LOD < 2.5) in the SE population in which their contribution to the traits was "masked" due to pleiotropic effects of erucic acid genes. The novel loci identified in this study could now be used to improve oil quality parameters and oil content in B. juncea under zero-erucic conditions.


Assuntos
Ácidos Erúcicos/química , Mostardeira/química , Mostardeira/genética , Óleos de Plantas/química , Locos de Características Quantitativas , Mapeamento Cromossômico , Cromossomos de Plantas , Cruzamentos Genéticos , Ligação Genética
12.
Genetics ; 182(3): 757-69, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19433630

RESUMO

To gain new mechanistic insight into ER homeostasis and the biogenesis of secretory proteins, we screened a genomewide collection of yeast mutants for defective intracellular retention of the ER chaperone, Kar2p. We identified 87 Kar2p-secreting strains, including a number of known components in secretory protein modification and sorting. Further characterization of the 73 nonessential Kar2p retention mutants revealed roles for a number of novel gene products in protein glycosylation, GPI-anchor attachment, ER quality control, and retrieval of escaped ER residents. A subset of these mutants, required for ER retrieval, included the GET complex and two novel proteins that likely function similarly in membrane insertion of tail-anchored proteins. Finally, the variant histone, Htz1p, and its acetylation state seem to play an important role in maintaining ER retrieval pathways, suggesting a surprising link between chromatin remodeling and ER homeostasis.


Assuntos
Retículo Endoplasmático/metabolismo , Genoma Fúngico , Homeostase/fisiologia , Processamento de Proteína Pós-Traducional/fisiologia , Transdução de Sinais/fisiologia , Acetilação , Proteínas Fúngicas/química , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Glicosilação , Complexo de Golgi/metabolismo , Proteínas de Choque Térmico HSP70/química , Proteínas de Choque Térmico HSP70/genética , Proteínas de Choque Térmico HSP70/metabolismo , Histonas/genética , Histonas/metabolismo , Immunoblotting , Imunoprecipitação , Modelos Biológicos , Mutação , Dobramento de Proteína , Receptores de Peptídeos/genética , Receptores de Peptídeos/metabolismo , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/fisiologia , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo , Transdução de Sinais/genética
13.
Genetics ; 181(1): 289-300, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18957706

RESUMO

A genomic collection of haploid Saccharomyces cerevisiae deletion strains provides a unique resource for systematic analysis of gene interactions. Double-mutant haploid strains can be constructed by the synthetic genetic array (SGA) method, wherein a query mutation is introduced by mating to mutant arrays, selection of diploid double mutants, induction of meiosis, and selection of recombinant haploid double-mutant progeny. The mechanism of haploid selection is mating-type-regulated auxotrophy (MRA), by which prototrophy is restricted to a particular haploid genotype generated only as a result of meiosis. MRA escape leads to false-negative genetic interaction results because postmeiotic haploids that are supposed to be under negative selection instead proliferate and mate, forming diploids that are heterozygous at interacting loci, masking phenotypes that would be observed in a pure haploid double-mutant culture. This work identified factors that reduce MRA escape, including insertion of terminator and repressor sequences upstream of the MRA cassette, deletion of silent mating-type loci, and utilization of alpha-type instead of a-type MRA. Modifications engineered to reduce haploid MRA escape reduced false negative results in SGA-type analysis, resulting in >95% sensitivity for detecting gene-gene interactions.


Assuntos
Genes Fúngicos Tipo Acasalamento , Técnicas Genéticas , Mutação/genética , Saccharomyces cerevisiae/genética , 3-Isopropilmalato Desidrogenase/genética , Sequência de Bases , Canavanina/farmacologia , Cromossomos Fúngicos/genética , Contagem de Colônia Microbiana , Cisteína/análogos & derivados , Cisteína/farmacologia , Diploide , Deleção de Genes , Haploidia , Heterozigoto , Meiose/efeitos dos fármacos , Fenótipo , Regiões Promotoras Genéticas/genética , Saccharomyces cerevisiae/citologia , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/crescimento & desenvolvimento , Proteínas de Saccharomyces cerevisiae/genética , Seleção Genética , Regiões Terminadoras Genéticas/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...